Ethics Approval
SECONDARY
The Meta-LARC ACP study was reviewed and approved by the Trial Innovation Network Central Institutional Review Board (IRB) at Vanderbilt University (VUMC IRB#181084) for the sites in the United States. As this study analyzes data without additional primary data collection, this secondary analysis was approved by the Duke University IRB (Pro00106329) with a waiver of consent. Data include protected health information data, which are stored in secure university-approved systems. There was no compensation for this additional analysis.